Antibe Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.257; its P/E ratio is -0.83; Antibe Therapeutics is scheduled to report earnings on June 27, 2024, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	C$ -4.21M	C$ -5.00M	C$ -5.78M	C$ -3.23M	C$ -4.20M
EBITDA	C$ -4.21M	C$ -5.00M	C$ -5.78M	C$ -3.23M	C$ -4.20M
Net Income Common Stockholders	C$ -4.21M	C$ -5.01M	C$ -5.79M	C$ -3.55M	C$ -4.32M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	C$ 24.91M	C$ 4.14M	C$ 8.79M	C$ 6.75M	C$ 10.53M
Total Assets	C$ 56.36M	C$ 60.20M	C$ 66.84M	C$ 70.56M	C$ 73.73M
Total Debt	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Net Debt	C$ -24.91M	C$ -4.14M	C$ -8.79M	C$ -6.75M	C$ -10.53M
Total Liabilities	C$ 30.43M	C$ 30.50M	C$ 32.04M	C$ 30.39M	C$ 30.47M
Stockholders Equity	C$ 25.94M	C$ 29.71M	C$ 34.80M	C$ 40.17M	C$ 43.26M
Cash Flow	-
Free Cash Flow	C$ -3.85M	C$ -6.43M	C$ -4.58M	C$ -3.38M	C$ -12.93M
Operating Cash Flow	C$ -3.85M	C$ -6.43M	C$ -4.58M	C$ -3.38M	C$ -12.92M
Investing Cash Flow	C$ 11.04M	C$ 1.78M	C$ 6.62M	C$ -549.00K	C$ -11.28M
Financing Cash Flow	-	-	-	C$ 159.00K	C$ -79.00K

Currency in CAD

Antibe Therapeutics Earnings and Revenue History

Income Statement >

Antibe Therapeutics Debt to Assets

Balance Sheet >

Antibe Therapeutics Cash Flow

Cash Flow >

Antibe Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing